OxyContin Abuse-Deterrent Postmarketing Data Are In. Now What?

 
• By Brenda Sandburg
  
Road concept - next step
FDA to decide how to convey results of reformulated OxyContin postmarketing studies • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers